These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33075345)
21. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review). Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057 [TBL] [Abstract][Full Text] [Related]
23. ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019). Foroozanfar E; Forouzanfar M; Farkhondeh T; Samarghandian S; Forouzanfar F Curr Drug Discov Technol; 2021; 18(6):e130921189567. PubMed ID: 33371835 [TBL] [Abstract][Full Text] [Related]
24. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon. Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959 [TBL] [Abstract][Full Text] [Related]
25. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
26. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263 [TBL] [Abstract][Full Text] [Related]
27. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
28. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice. Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370 [TBL] [Abstract][Full Text] [Related]
29. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery. Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470 [TBL] [Abstract][Full Text] [Related]
30. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354 [No Abstract] [Full Text] [Related]
31. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract. Galanopoulos M; Doukatas A; Gazouli M World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196 [TBL] [Abstract][Full Text] [Related]
32. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues. Hu RW; Liu C; Gong JP; Cao ZX Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2409-2414. PubMed ID: 33755980 [TBL] [Abstract][Full Text] [Related]
33. Coronavirus infection: An immunologists' perspective. De Sanctis JB; García AH; Moreno D; Hajduch M Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027 [TBL] [Abstract][Full Text] [Related]
34. Alveolar type II cells and pulmonary surfactant in COVID-19 era. Calkovska A; Kolomaznik M; Calkovsky V Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352 [TBL] [Abstract][Full Text] [Related]
36. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788 [TBL] [Abstract][Full Text] [Related]
37. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890 [TBL] [Abstract][Full Text] [Related]
38. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427 [TBL] [Abstract][Full Text] [Related]
39. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786 [TBL] [Abstract][Full Text] [Related]
40. Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway. Afshari A; Janfeshan S; Yaghobi R; Roozbeh J; Azarpira N Infect Genet Evol; 2021 Mar; 88():104669. PubMed ID: 33301988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]